Metronidazole Biosedra

Metronidazole, the active ingredient in Metronidazole Biosedra, is a Nitroimidazole presented as an injectable solution for Intravenous use. It treats anaerobic bacterial infections and related conditions in adult patients.

GNH USA supplies Metronidazole Biosedra as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole Biosedra is a nitroimidazole antibiotic that targets anaerobic bacteria and protozoa.

- Anaerobic bacterial infections: eradicates susceptible anaerobes and resolves infection. - Bacterial vaginosis: restores normal vaginal flora by eliminating pathogenic anaerobes. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms. - Amebic liver abscess: destroys Entamoeba histolytica trophozoites in hepatic tissue. - Clostridioides difficile infection: reduces toxin‑producing C. difficile and aids clinical recovery.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate headache. - Diarrhea: loose stools, often self‑limited. - Abdominal pain: cramping or discomfort. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis, rash, or swelling. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Liver toxicity: elevated transaminases or hepatitis. - Neutropenia: marked reduction in white blood cells.

Before using Metronidazole Biosedra, consider the following safety measures.

- Renal impairment: adjust therapy and monitor renal function. - Hepatic disease: use with caution and monitor liver enzymes. - Alcohol consumption: avoid to prevent disulfiram‑like reaction. - Pregnancy: prescribe only if benefit outweighs potential risk. - Concurrent warfarin therapy: monitor INR closely for increased anticoagulation. - Store at ambient temperature: keep in original container, protect from light and moisture.

Metronidazole can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Warfarin: increased anticoagulant effect, risk of bleeding. - Lithium: heightened lithium toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma levels. - Phenobarbital: may reduce metronidazole efficacy. - Phenytoin: may lower metronidazole concentrations.